The latest clinical diagnosis and treatment guidelines for lung cancer issued by the Chinese Medical Association recommended that examination of EGFR, ALK, ROS1 were indispensable for NSCLC detection and other genes including BRAF, MET, HER2, KRAS and RET should also be considered for NSCLC detection 26. The gene discussed is BRAF; the disease is non-small cell lung carcinoma.